about
sameAs
The role of genetics in inflammatory bowel disease.New serological markers in inflammatory bowel disease are associated with complicated disease behaviourEtrolizumab for induction of remission in ulcerative colitisAnti-MAdCAM antibody for induction of remission in ulcerative colitisUse of biologics and chemotherapy in patients with inflammatory bowel diseases and cancerRecommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensusManagement of inflammatory bowel disease in pregnancyWithdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel diseaseReview article: anti-adhesion therapies for inflammatory bowel diseaseThe role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel diseaseDefining Disease Severity in Inflammatory Bowel Diseases: Current and Future DirectionsSecond European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)The value of serologic markers in indeterminate colitis: a prospective follow-up studyProgressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's diseaseReview article: Infliximab therapy for inflammatory bowel disease--seven years onNovel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL).Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's diseaseMucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment.Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversity.Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy.Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's diseaseGenetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease.Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic reviewThe second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's diseaseSmall bowel review: Normal physiology, part 1.Small bowel review: Normal physiology, part 2.A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial.Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial.Infliximab: the evidence for its place in therapy in ulcerative colitis.Prevalence of CARD15/NOD2 mutations in Caucasian healthy people.Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series.Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis.
P50
Q22241333-EAD0B4AF-947E-46A3-B303-96EAE903DFDDQ22242048-B2E88231-A10D-4259-9827-99394F99B455Q24186788-3C4E4C53-6863-4672-95F5-A6DD9FE2EC62Q24187593-CB4ADA07-A268-450B-A34D-9805FE7A6550Q26750190-AEDFBF61-E6B8-42E1-995C-F46517CAA811Q26852581-74BDE6CD-AB5C-43C1-9E4A-88D349A75F7EQ26865914-B396B649-C410-4928-992F-84536DE7FBFDQ26866281-9516E3D7-BC7D-4885-8AD8-C7E23D96627FQ26999705-F9B0280F-2A25-4A8A-B522-DDB4EB14234EQ27007776-0BA16476-9C74-4711-AEDE-3523C70C245AQ28087314-FA581426-1B33-4632-9D50-53FDE74CFB9AQ28088404-00564574-E33F-4FB8-9B07-74BDA7C7DB47Q28216203-96F6C3A6-DB2B-46AF-B0D1-A9378AA995B2Q28255557-3C59319B-761A-4C68-8126-1749BD9B242BQ28294134-3976FB22-C7DA-44DA-A5CE-F1800FBF6031Q28469186-1D761B03-A598-4380-9CE6-A459DCC3EED8Q28943305-6D20E680-36E8-495B-90E7-8B3C05707A80Q28943462-6AFE5994-3D39-4B48-949F-C423184CA007Q29417124-FCDA38AE-73DF-4BB4-9D2C-224F1495CA22Q30416155-CA9C6691-AB0B-41D8-B715-4549C4F25276Q30657855-35DA2AB0-2A83-46E0-B876-AAC2C66DC170Q30945619-344DBFCC-3E32-4357-895D-62051F7EF326Q33245349-82330F21-D6CE-4B53-AD42-07F4A50C5834Q33401933-5E9AF2F4-341B-4C8D-A3EA-8759AA6E9CC1Q33409853-E51B8A17-B0F6-40D2-B69E-D82714D4F46BQ33507084-A248FDFA-B824-43ED-A4E6-BA54E4D7FE00Q33766675-67E02697-064C-4762-B7E3-A21A25BF7271Q34023277-F17BD889-6788-424B-9F71-F355C53B1BCBQ34152778-3B4CC8BC-1B45-4E94-B861-C573271B730DQ34185576-BB6D4F79-60EF-4B38-B04F-69351DE60439Q34223385-29D56BB7-5423-48DA-8493-09D756177C58Q34223392-C98491A4-FF6F-4CF2-9B46-1770D37492CFQ34369987-EA356365-327A-4F49-815C-C2FBF0AA66BBQ34410821-EC5A868D-93A5-4EFC-B686-6210F61246BBQ34431219-4603B029-8021-415E-8EB3-B236E9773CE3Q34449876-DB00010D-E442-4747-8386-496CA9A55C3EQ34576207-B3BFC470-02C7-4AF8-8DAC-686C22D267E4Q34606666-3C9CE0F5-7791-4ED2-85F7-AC53312EC923Q34610304-32A7FAF6-C743-47BB-9D03-014163197518Q34622749-262E8745-A39C-4586-9878-C0FEC70AC726
P50
description
Belgian gastroenterologist
@en
Belgisch onderzoekster
@nl
belgische Gastroenterologin
@de
հետազոտող
@hy
name
Severine Vermeire
@sq
Séverine Vermeire
@ast
Séverine Vermeire
@de
Séverine Vermeire
@en
Séverine Vermeire
@es
Séverine Vermeire
@fr
Séverine Vermeire
@it
Séverine Vermeire
@nl
Séverine Vermeire
@sl
type
label
Severine Vermeire
@sq
Séverine Vermeire
@ast
Séverine Vermeire
@de
Séverine Vermeire
@en
Séverine Vermeire
@es
Séverine Vermeire
@fr
Séverine Vermeire
@it
Séverine Vermeire
@nl
Séverine Vermeire
@sl
altLabel
S Vermeire
@en
Severine Vermeire
@en
prefLabel
Severine Vermeire
@sq
Séverine Vermeire
@ast
Séverine Vermeire
@de
Séverine Vermeire
@en
Séverine Vermeire
@es
Séverine Vermeire
@fr
Séverine Vermeire
@it
Séverine Vermeire
@nl
Séverine Vermeire
@sl
P106
P1153
7003726576
P21
P27
P31
P496
0000-0001-9942-3019